There is ‘a lot more pushback’ on data center construction, Berkshire CEO Greg Abel tells CNBCSeptember 11, 2026
Manhattan BioSolutions, Inc. Signs Commercial Evaluation License Agreements with the National Institutes of Health (NIH) for Use of Monoclonal Antibodies in Novel Antibody-Drug Conjugate (ADC) Oncology Programs Markets July 20, 2022 NEW YORK, NY / ACCESSWIRE / July 20, 2022 / Manhattan BioSolutions, Inc. at this time introduced it has entered…
